Jenkem Technology Co

Jenkem Technology Co Dividend Coverage

The Dividend Coverage Ratio of Jenkem Technology Co (688356.SS) as of Oct 16, 2026 is 7.14. In the previous year, Dividend Coverage Ratio was 0.84 — a change of 754.44% (higher).

Dividend Coverage

7.14

YoY

754.44%

Last updated:

Dividend Coverage Ratio of Jenkem Technology Co is 2025 7.14 . Dividend Coverage Ratio of Jenkem Technology Co was 2024 0.84 . It decreases by 754.44% higher compared to the previous year.

The Jenkem Technology Co Dividend Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend Coverage
Date
Dividend Coverage
Jan 1, 2021
6.58 CNY
Jan 1, 2022
3.52 CNY
Jan 1, 2023
2.05 CNY
Jan 1, 2024
0.84 CNY
Jan 1, 2025
7.14 CNY
The Jenkem Technology Co Dividend Coverage history
YEARDividend CoverageYoY
7.14+754.44%
0.84-59.14%
2.05-41.80%
3.52-46.58%
6.58—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Jenkem Technology Co Stock analysis

What does Jenkem Technology Co do? Jenkem Technology Co Ltd is a pharmaceutical company based in Beijing, China, operating within the healthcare sector. The company focuses on the research, development, production, and sales of medical polyethylene glycol (PEG) and its active derivatives. With 252 employees, Jenkem Technology serves various industries including drug and medical device manufacturing, scientific research institutions, and other related fields. The company went public on the Shanghai Stock Exchange on August 26, 2020, with the ticker symbol 688356.SS. Its primary products are utilized in the development and production processes of pharmaceuticals and medical technologies. Jenkem Technology also provides technical services such as patent and non-patent technology licensing, as well as research and development support. The company's headquarters are located in Beijing, and it maintains a corporate website at www.jenkem.com. Jenkem Technology operates as a publicly traded entity, offering its services and products primarily to the healthcare and research sectors. The firm's activities are centered around the production and application of PEG-based materials, which are essential in various medical and scientific applications. The company's operational scope includes both domestic and international markets, though specific market details are not provided. Jenkem Technology's business model emphasizes innovation in medical materials, particularly through its focus on PEG and its derivatives. The company's IPO date marks a significant milestone in its growth trajectory, reflecting its transition to a publicly listed entity. The firm's product portfolio and services are designed to support the broader healthcare industry's needs in research and development. Jenkem Technology's operations are grounded in the production of key materials used in pharmaceutical and medical device manufacturing, contributing to advancements in healthcare technology. Jenkem Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jenkem Technology Co stock

Dividend Coverage Ratio of Jenkem Technology Co is 7.14 in 2025.

Dividend Coverage Ratio of Jenkem Technology Co changed from 0.84 to 7.14, representing a 754.44% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio Jenkem Technology Co since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's Jenkem Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Jenkem Technology Co

All Key Metrics — Jenkem Technology Co